Elevance Health (ELV) Stock Price, News & Analysis

Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Key Stats

• Today's Range: $364.86 to $372.00
• 50-Day Range: $365.96 to $509.58
• 52-Week Range: $362.21 to $567.26
• Volume: 3.44 million shs
• Average Volume: 1.25 million shs
• Market Capitalization: $84.87 billion
• P/E Ratio: 13.34
• Dividend Yield: 1.78%
• Price Target: $539.20
• Consensus Rating: Moderate Buy

Elevance Health Stock Analysis - MarketRank™

Elevance Health scored higher than 97% of companies evaluated by MarketBeat, and ranked 42nd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Elevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.81, and is based on 12 buy ratings, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Elevance Health has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.22%

Earnings Growth

Earnings for Elevance Health are expected to grow by 7.22% in the coming year, from $32.96 to $35.34 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Elevance Health is 13.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.29.

Price to Earnings Ratio vs. Sector

The P/E ratio of Elevance Health is 13.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.58.

Price to Earnings Growth Ratio

Elevance Health has a PEG Ratio of 1.15. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Elevance Health has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.22% of the float of Elevance Health has been sold short.

Short Interest Ratio / Days to Cover

Elevance Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Elevance Health has recently decreased by 9.90%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Elevance Health pays a meaningful dividend of 1.78%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Elevance Health has been increasing its dividend for 13 years.

Dividend Coverage

The dividend payout ratio of Elevance Health is 23.77%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Elevance Health will have a dividend payout ratio of 18.45% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.22% of the float of Elevance Health has been sold short.

Short Interest Ratio / Days to Cover

Elevance Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Elevance Health has recently decreased by 9.90%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: 0.32

News Sentiment

Elevance Health has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Elevance Health this week, compared to 14 articles on an average week.

Search Interest

Only 26 people have searched for ELV on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.

MarketBeat Follows

Only 24 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Elevance Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,205,182.00 in company stock.

Percentage Held by Insiders

Only 0.35% of the stock of Elevance Health is held by insiders.

Percentage Held by Institutions

89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ELV Stock Analysis - Frequently Asked Questions

How have ELV shares performed this year?

Elevance Health's stock was trading at $471.56 at the beginning of 2024. Since then, ELV stock has decreased by 22.4% and is now trading at $365.96.
View the best growth stocks for 2024 here.

How were Elevance Health's earnings last quarter?

Elevance Health, Inc. (NYSE:ELV) posted its earnings results on Thursday, October, 17th. The company reported $8.37 EPS for the quarter, missing the consensus estimate of $9.66 by $1.29. The company's revenue for the quarter was up 5.3% on a year-over-year basis.

Does Elevance Health have any subsidiaries?

Elevance Health subsidiaries include Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and others.

Who are Elevance Health's major shareholders?

Elevance Health's top institutional investors include State Street Corp (4.61%), Geode Capital Management LLC (2.09%), FMR LLC (1.99%) and Sanders Capital LLC (1.99%). Insiders that own company stock include Gail Boudreaux, Gloria M Mccarthy, Felicia F Norwood, Robert L Dixon Jr, Ramiro G Peru, Charles Morgan Kendrick Jr, Ronald W Penczek and Peter D Haytaian.
View institutional ownership trends.

How do I buy shares of Elevance Health?

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Elevance Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Advanced Micro Devices (AMD), Bristol-Myers Squibb (BMY), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Ex-Dividend for 9/25 Dividend: 9/10/2024
• Dividend Payable: 9/25/2024
• Last Earnings: 10/17/2024
• Ex-Dividend for 12/20 Dividend: 12/05/2024
• Dividend Payable: 12/20/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Hospital & medical service plans
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:ELV
• CUSIP: 94973V10
• CIK: 1156039
• Web: www.antheminc.com
• Phone: (800) 331-1476
• Fax: 317-488-6275
• Employees: 104,900
• Year Founded: 2004

Price Target and Rating

• Average Stock Price Target: $539.20
• High Stock Price Target: $649.00
• Low Stock Price Target: $478.00
• Potential Upside/Downside: +47.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.81
• Research Coverage: 16 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $27.43
• Trailing P/E Ratio: 13.34
• Forward P/E Ratio: 11.10
• P/E Growth: 1.15
• Net Income: $5.99 billion
• Net Margins: 3.68%
• Pretax Margin: 4.76%
• Return on Equity: 19.56%
• Return on Assets: 7.22%

Debt

• Debt-to-Equity Ratio: 0.56
• Current Ratio: 1.50
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: $174.02 billion
• Price / Sales: 0.49
• Cash Flow: $39.14 per share
• Price / Cash Flow: 9.35
• Book Value: $169.07 per share
• Price / Book: 2.16

Miscellaneous

• Outstanding Shares: 231,923,000
• Free Float: 231,111,000
• Market Cap: $84.87 billion
• Optionable: Optionable
• Beta: 0.83